Pastāsti draugiem par šo preci:
Combination Studies with the Vascular Disrupting Agent Ca4p: Clinical Studies Combined with Chemotherapy and Radioimmunotherapy, and Dce-mri and Immunohistochemistry Correlation Andrew Gaya
Cena
€ 70,49
Pasūtīts no attālās noliktavas
Paredzamā piegāde . gada 23. nov. - . gada 1. dec.
Ziemassvētku dāvanas var atgriezt līdz 31. janvārim
Saņemiet paziņojumus par jauniem Andrew Gaya izdevumiem
Mūsu klienti saka:
Pievienot savam iMusic vēlmju sarakstam
Combination Studies with the Vascular Disrupting Agent Ca4p: Clinical Studies Combined with Chemotherapy and Radioimmunotherapy, and Dce-mri and Immunohistochemistry Correlation
Andrew Gaya
This work represents studies carried out at Mount Vernon Hospital and UCL, and sponsored by Cancer Research UK, between 2003 and 2006. Phase I/II Clinical trial studies of the vascular disrupting agent Combretastatin A4 Phosphate (CA4P) are presented - in combination with cytotoxic chemotherapy (Paclitaxel and Carboplatin), and radioimmunotherapy. Dynamic Contrast Enhanced MRI data from the studies is presented and discussed, and a supporting immunohistochemistry correlation study of vascular markers is also presented.
| Mediji | Grāmatas Paperback Book (Grāmata ar mīksto vāku un līmēto muguru) |
| Izlaists | 2011. gada 10. maijs |
| ISBN13 | 9783838343532 |
| Izdevēji | LAP LAMBERT Academic Publishing |
| Lapas | 256 |
| Izmēri | 150 × 15 × 226 mm · 399 g |
| Valoda | Vācu |
Skatīt visus Andrew Gaya